Sophia Genetics Sa Stock Market Value
| SOPH Stock | USD 5.25 0.08 1.55% |
| Symbol | Sophia |
Is there potential for Health Care Equipment & Supplies market expansion? Will Sophia introduce new products? Factors like these will boost the valuation of Sophia Genetics. If investors know Sophia will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Sophia Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share | Quarterly Revenue Growth 0.228 | Return On Assets | Return On Equity |
The market value of Sophia Genetics SA is measured differently than its book value, which is the value of Sophia that is recorded on the company's balance sheet. Investors also form their own opinion of Sophia Genetics' value that differs from its market value or its book value, called intrinsic value, which is Sophia Genetics' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Sophia Genetics' market value can be influenced by many factors that don't directly affect Sophia Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sophia Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sophia Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Sophia Genetics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Sophia Genetics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sophia Genetics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sophia Genetics.
| 11/02/2025 |
| 01/31/2026 |
If you would invest 0.00 in Sophia Genetics on November 2, 2025 and sell it all today you would earn a total of 0.00 from holding Sophia Genetics SA or generate 0.0% return on investment in Sophia Genetics over 90 days. Sophia Genetics is related to or competes with Simulations Plus, Definitive Healthcare, Kindly MD, Alto Neuroscience, Cellectis, National Research, and OPTIMIZERx Corp. SOPHiA GENETICS SA operates as a healthcare technology company More
Sophia Genetics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sophia Genetics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sophia Genetics SA upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.24 | |||
| Information Ratio | 0.0743 | |||
| Maximum Drawdown | 22.25 | |||
| Value At Risk | (6.03) | |||
| Potential Upside | 7.05 |
Sophia Genetics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sophia Genetics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sophia Genetics' standard deviation. In reality, there are many statistical measures that can use Sophia Genetics historical prices to predict the future Sophia Genetics' volatility.| Risk Adjusted Performance | 0.0724 | |||
| Jensen Alpha | 0.3174 | |||
| Total Risk Alpha | 0.0675 | |||
| Sortino Ratio | 0.1016 | |||
| Treynor Ratio | 0.3108 |
Sophia Genetics January 31, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0724 | |||
| Market Risk Adjusted Performance | 0.3208 | |||
| Mean Deviation | 3.21 | |||
| Semi Deviation | 2.96 | |||
| Downside Deviation | 3.24 | |||
| Coefficient Of Variation | 1133.82 | |||
| Standard Deviation | 4.42 | |||
| Variance | 19.56 | |||
| Information Ratio | 0.0743 | |||
| Jensen Alpha | 0.3174 | |||
| Total Risk Alpha | 0.0675 | |||
| Sortino Ratio | 0.1016 | |||
| Treynor Ratio | 0.3108 | |||
| Maximum Drawdown | 22.25 | |||
| Value At Risk | (6.03) | |||
| Potential Upside | 7.05 | |||
| Downside Variance | 10.48 | |||
| Semi Variance | 8.74 | |||
| Expected Short fall | (4.31) | |||
| Skewness | 1.33 | |||
| Kurtosis | 3.12 |
Sophia Genetics SA Backtested Returns
Sophia Genetics is slightly risky at the moment. Sophia Genetics SA owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0392, which indicates the firm had a 0.0392 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Sophia Genetics SA, which you can use to evaluate the volatility of the company. Please validate Sophia Genetics' Coefficient Of Variation of 1133.82, risk adjusted performance of 0.0724, and Semi Deviation of 2.96 to confirm if the risk estimate we provide is consistent with the expected return of 0.15%. Sophia Genetics has a performance score of 3 on a scale of 0 to 100. The entity has a beta of 1.22, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sophia Genetics will likely underperform. Sophia Genetics SA right now has a risk of 3.95%. Please validate Sophia Genetics skewness, and the relationship between the value at risk and day median price , to decide if Sophia Genetics will be following its existing price patterns.
Auto-correlation | 0.65 |
Good predictability
Sophia Genetics SA has good predictability. Overlapping area represents the amount of predictability between Sophia Genetics time series from 2nd of November 2025 to 17th of December 2025 and 17th of December 2025 to 31st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sophia Genetics SA price movement. The serial correlation of 0.65 indicates that roughly 65.0% of current Sophia Genetics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.65 | |
| Spearman Rank Test | 0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 0.09 |
Currently Active Assets on Macroaxis
When determining whether Sophia Genetics SA offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sophia Genetics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sophia Genetics Sa Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sophia Genetics Sa Stock:Check out Sophia Genetics Correlation, Sophia Genetics Volatility and Sophia Genetics Performance module to complement your research on Sophia Genetics. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Sophia Genetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.